Leica Microsystems has acquired ATTO-TEC, enhancing its microscopy portfolio with specialized fluorescent dyes and reagents to better support researchers across all stages of the imaging workflow.

Target Information

Leica Microsystems, based in Wetzlar, Germany, is a prominent leader in the field of microscopy and scientific instrumentation, known for its advanced imaging solutions. The company has announced the acquisition of ATTO-TEC, a distinguished supplier specializing in fluorescent dyes and reagents. This strategic acquisition will enhance Leica's existing portfolio, which includes high-end microscopy imaging platforms and AI-driven analysis software, by integrating dyes and reagents essential for sample preparation.

ATTO-TEC is recognized for its high-quality, specialized products that have established a benchmark in fluorescence microscopy imaging. Its product range includes ATTO dyes, antibody labeling kits, labeled phospholipids, and various reagents that support rigorous scientific research, particularly in cancer studies.

Industry Overview

The microscopy industry is experiencing significant advancements globally, driven by the increasing demand for precise imaging technology in research and clinical applications. In Germany, a country renowned for its engine

View Source

Similar Deals

Cinven SYNLAB AG

2025

Buyout Medical & Diagnostic Laboratories Germany
Beyond Capital Partners Fund II blu GmbH

2025

Buyout Medical Supplies Germany
Odewald KMU III Softdoor

2025

Buyout Healthcare Facilities & Services (NEC) Germany
Demant A/S OHRWERK Gruppe

2025

Buyout Healthcare Facilities & Services (NEC) Germany
AIF Capital Group Haus Melchior

2025

Buyout Residential & Long-Term Care Germany
LTS LOHMANN Therapie-Systeme AG Renaissance Lakewood, LLC

2025

Buyout Hospitals, Clinics & Primary Care Services Germany

Leica Microsystems

invested in

ATTO-TEC

in 2025

in a Buyout deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert